Literature DB >> 12719684

Is it simple or simplistic?

Geoffrey R Norman1, Jeff A Sloan, Kathleen W Wyrwich.   

Abstract

Mesh：

Year:  2003        PMID： 12719684     DOI： 10.1097/01.MLR.0000062556.73534.61

Source DB:  PubMed          Journal:  Med Care        ISSN： 0025-7079            Impact factor:   2.983


× No keyword cloud information.
  6 in total

1.  Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

Authors:  Marc D Schwartz; Heiddis B Valdimarsdottir; Beth N Peshkin; Jeanne Mandelblatt; Rachel Nusbaum; An-Tsun Huang; Yaojen Chang; Kristi Graves; Claudine Isaacs; Marie Wood; Wendy McKinnon; Judy Garber; Shelley McCormick; Anita Y Kinney; George Luta; Sarah Kelleher; Kara-Grace Leventhal; Patti Vegella; Angie Tong; Lesley King
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

2.  Clinical benefit of response in chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Paul J Martin; Xiaoyu Chai; Madan Jagasia; Jeanne Palmer; Joseph Pidala; Corey Cutler; Steven Z Pavletic; Mukta Arora; David Jacobsohn; Paul A Carpenter; Mary E D Flowers; Nandita Khera; Georgia B Vogelsang; Daniel Weisdorf; Barry E Storer; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-06       Impact factor: 5.742

3.  Validation of measurement scales in ocular graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Xiaoyu Chai; Brenda F Kurland; Corey Cutler; Mary E D Flowers; Jeanne M Palmer; Paul A Carpenter; Mary J Heffernan; David Jacobsohn; Madan H Jagasia; Joseph Pidala; Nandita Khera; Georgia B Vogelsang; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Stephanie J Lee
Journal:  Ophthalmology       Date:  2011-12-06       Impact factor: 12.079

4.  Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

Authors:  Stephanie J Lee; Daniel Wolff; Carrie Kitko; John Koreth; Yoshihiro Inamoto; Madan Jagasia; Joseph Pidala; Attilio Olivieri; Paul J Martin; Donna Przepiorka; Iskra Pusic; Fiona Dignan; Sandra A Mitchell; Anita Lawitschka; David Jacobsohn; Anne M Hall; Mary E D Flowers; Kirk R Schultz; Georgia Vogelsang; Steven Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-19       Impact factor: 5.742

5.  Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.

Authors:  Mary K Interrante; Hannah Segal; Beth N Peshkin; Heiddis B Valdimarsdottir; Rachel Nusbaum; Morgan Similuk; Tiffani DeMarco; Gillian Hooker; Kristi Graves; Claudine Isaacs; Marie Wood; Wendy McKinnon; Judy Garber; Shelley McCormick; Jessica Heinzmann; Anita Y Kinney; Marc D Schwartz
Journal:  JNCI Cancer Spectr       Date:  2017-09-22

6.  Acceptance and Commitment Therapy for Muscle Disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases.

Authors:  Michael R Rose; Sam Norton; Chiara Vari; Victoria Edwards; Lance McCracken; Christopher D Graham; Aleksandar Radunovic; Trudie Chalder
Journal:  BMJ Open       Date:  2018-10-03       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.